Back to Search
Start Over
Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis.
- Source :
- Infection; Oct2024, Vol. 52 Issue 5, p2029-2042, 14p
- Publication Year :
- 2024
-
Abstract
- Background: This meta-analysis was conducted to compare the efficacy of ceftazidime-avibactam combination therapy with that of monotherapy in the treatment of carbapenem-resistant Gram-negative bacterial (CR-GNB). Methods: A literature search of PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov was conducted until September 1, 2023. Only studies that compared CZA combination therapy with monotherapy for CR-GNB infections were included. Results: A total of 25 studies (23 retrospective observational studies and 2 prospective studies) involving 2676 patients were included. There was no significant difference in 30-day mortality between the study group receiving combination therapy and the control group receiving monotherapy (risk ratio [RR] 0.91; 95% confidence interval [CI] 0.71–1.18). In addition, no significant differences were observed between the study and the control group in terms of in-hospital mortality (RR 1.00; 95% CI 0.79–1.27), 14-day mortality (RR 1.54; 95% CI 0.24–9.91), 90-day mortality (RR 1.18; 95% CI 0.62–2.22), and clinical cure rate (RR 0.95; 95% CI 0.84–1.08). However, the combination group had a borderline higher microbiological eradication rate than the control group (RR 1.15; 95% CI 1.00–1.32). Conclusions: Compared to monotherapy, CZA combination therapy did not yield additional clinical benefits. However, combination therapy may be associated with favorable microbiological outcomes. [ABSTRACT FROM AUTHOR]
- Subjects :
- ANTIBIOTICS
CARBAPENEMS
MEDICAL information storage & retrieval systems
ENZYME inhibitors
DRUG resistance in microorganisms
META-analysis
DESCRIPTIVE statistics
HOSPITAL mortality
SYSTEMATIC reviews
MEDLINE
ODDS ratio
DRUG efficacy
MEDICAL databases
GRAM-negative bacterial diseases
CEFTAZIDIME
BETA lactamases
ONLINE information services
CONFIDENCE intervals
EVALUATION
CHEMICAL inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 03008126
- Volume :
- 52
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Infection
- Publication Type :
- Academic Journal
- Accession number :
- 180456889
- Full Text :
- https://doi.org/10.1007/s15010-024-02277-y